Skip to main content

Table 2 Complications and outcome of patients.

From: Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit

 

TPN with Gl (n = 23)

TPN without Gl (n = 20)

P-value

Infections, n (%)

   

   Respiratory infection

14 (61%)

14 (70%)

0.53

   Urinary infection

1 (4%)

2 (10%)

0.6

   Blood culture

1 (4%)

5 (25%)

0.08

   Catheter infection

4 (17%)

6 (30%)

0.5

   CSF infection

1 (4%)

1 (5%)

0.6

   Wound infection

0 (0%)

4 (20%)

0.08

   Pneumonia

11 (48%)

8 (40%)

0.6

Length of MV (days)

15.2 ± 8.2

18.9 ± 11.1

0.21

ICU length of stay (days)

21 (17 to 25)

21 (14 to 47)

0.47

Hospital length of stay (days)

31 (19 to 42)

40 (24 to 80)

0.23

ICU mortality

4 (17%)

2 (10%)

0.7

Hospital mortality

0 (0%)

1 (5%)

1

  1. Data are presented as mean±SD or median (25th to 75th percentile).
  2. Respiratory infection, number of positive bronchial aspirate cultures during ICU admission; Urinary infection, number of positive urine cultures during ICU admission; Blood culture, number of positive blood cultures during ICU admission; Catheter infection, number of positive blood cultures during ICU admission; CSF infection, number of positive cultures of Cerebro Spinal Fluid; Wound infection, number of positive cultures in the wound zone; Pneumonia, number of patients who developed nosocomial pneumonia during ICU admission; Length of MV, number of days of mechanical ventilation.
Back to article page

Critical Care

ISSN: 1364-8535